<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Government deals lift overhang on pharma group, says BofA

PremiumThe Fly

2d ago

Genentech announces FDA approval of CD20xCD3 bispecific Lunsumio Velo

PremiumThe Fly

2d ago

Roche CEO says drug prices in Switzerland to get higher in future, Reuters says

PremiumThe Fly

3d ago

Trump announces pacts with nine pharma companies to lower drug prices

PremiumThe Fly

5d ago

GSK

PremiumThe FlyGenentech reaches pact with US. to lower costs for state Medicaid programs

5d ago

Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports

The Fly

Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports

5d ago

Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says

The Fly

Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says

5d ago

Novartis, Roche nearing drug price deals with U.S., Bloomberg says

MRK

PremiumThe Fly

7d ago

NVS

Roche announces U.S. launch of next-generation cobas 6800/8800 systems

PremiumThe Fly

8d ago

Caris Life Sciences partners with Roche’s Genentechh for cancer targets

PremiumThe Fly

8d ago

CAI

Olema Oncology price target raised to $48 from $45 at Oppenheimer

PremiumThe Fly

13d ago

OLMA

PremiumThe FlyOlema Oncology price target raised to $43 from $30 at Jefferies

14d ago

OLMA

Roche reports data from Phase 3 lidERA Breast Cancer study

The Fly

Roche reports data from Phase 3 lidERA Breast Cancer study

14d ago

Roche price target raised to $57 from $50 at HSBC

The Fly

Roche price target raised to $57 from $50 at HSBC

14d ago

Roche announces European Commission approved Gazyva/Gazyvaro

PremiumThe Fly

15d ago

Roche presents Lunsumio data showing potential across lymphoma treatment lines

PremiumThe Fly

16d ago

Roche upgraded to Neutral from Underweight at JPMorgan

PremiumThe Fly

17d ago

Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’

PremiumThe Fly

19d ago

PremiumThe FlyFDA shift in drug study requirements sends trial runners lower

20d ago

FDA to reduce number of trials required for drug approvals, STAT reports

The Fly

FDA to reduce number of trials required for drug approvals, STAT reports

20d ago

The Fly

FDA to reduce number of trials required for drug approvals, STAT reports

20d ago